Results 181 to 190 of about 133,417 (336)

Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Thoracic Esophagus: Feasibility and Outcome of Large Regional Field and High-dose External Beam Boost Irradiation [PDF]

, 2001
Takafumi Toita
openalex   +1 more source

Outcomes of HPV+ Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic Surgery

The Laryngoscope, EarlyView.
ABSTRACT Objectives Treatment of patients with head and neck squamous cell carcinoma of unknown primary (CUP) is challenging. Given the relative rarity of this condition and the recent use of primary transoral robotic surgery (TORS) in modern diagnostic and treatment algorithms, long‐term oncologic outcomes are unclear.
Theodore A. Gobillot, Gregory Weinstein, Austin Cao, Jake J. Lee, Robert M. Brody, Devraj Basu, Bert W. O'Malley Jr, D. Gregory Farwell, Steven Cannady, Alexander Lin, John Lukens, Michelle Gentile, Jason G. Newman, Ara A. Chalian, Lova Sun, Deepak Lakshmipathy, Roger B. Cohen, Christopher H. Rasskeh, Karthik Rajasekaran   +18 more
wiley   +1 more source

CONCOMITANT INTRAARTERIAL CHEMORADIOTHERAPY FOR HEAD AND NECK CANCER EVALUATED BY FDG-PET

, 2000
Yoshimasa Kitagawa, Yoshiharu Yonekura, Kazuo Sano, Yoshihiro Maruta, Toshiyuki Ogasawara, Toru Ogawa, Masanori Yoshida   +6 more
openalex   +2 more sources

Robotic Resection of Parapharyngeal Follicular Dendritic Cell Sarcoma With Castleman Disease

The Laryngoscope, EarlyView.
Parapharyngeal follicular dendritic cell sarcoma (FDCS) is rare and may occur with Castleman disease. We describe the successful transoral robotic resection of a parapharyngeal FDCS associated with Castleman disease, highlighting the role of the robotic approach in achieving tissue diagnosis and definitive treatment.
Lily Huang, Aman M. Patel, Timothy Chao, Ryan M. Carey   +3 more
wiley   +1 more source

Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy. [PDF]

Trials
Cheng Y, Cao Y, Zhao S, Jin Q, Li J, Li C, Zhang Y, Shen W, He J, Wang M, Ji G, Li Z, He Y, Chen Q, Wei W, Tan L, Wang H, Shi Y, Li H.   +18 more
europepmc   +1 more source

Concurrent Chemoradiotherapy for Locally Unresectable Head and Neck Cancer.

, 2000
Naoyuki Kohno, Satoshi Kitahara, Etuyo Tamura, Tetuya Tanabe, Manabu Nakanoboh, Yasuo Itoh, Yasuhiro Murata, Taichi Furukawa   +7 more
openalex   +2 more sources

Tracheostomy Dependence in Hypopharyngeal Cancer: Comparative Prognostic Impact of CRT Versus Surgery

The Laryngoscope, EarlyView.
Patients with long‐term tracheostomy dependence exhibited the poorest prognosis and the highest recurrence rates. Emergency tracheostomy was identified as a strong predictor of long‐term dependence. Upfront surgery may be more appropriate for patients with impaired baseline laryngeal function.
Chien‐Yi Yang, Chun‐Shu Lin, Chieh Hsing Liu, Shao‐Cheng Liu   +3 more
wiley   +1 more source

Rad51 at the Crossroads: Bridging DNA Repair, Tumorigenesis, and Immune Regulation

Med Research, EarlyView.
Therapeutic landscape of Rad51 in cancer treatment. Key elements include (1) DNA damage sources (PARPi, chemo/radiotherapy); (2) repair pathways (Rad51‐mediated HR); (3) intervention strategies (Rad51 inhibitors, CRISPR/Cas9); and (4) combination approaches (immunotherapy). The figure is created with BioRender.com.
Zhendong Qin, Mingjun Lu, Jingwei Guo, Chenyang Wang, Teng Ma   +4 more
wiley   +1 more source

Efficacy of Endostar plus concurrent chemoradiotherapy in locally advanced cervical cancer: a multicenter, phase II randomized trial. [PDF]

Ther Adv Med Oncol
Wu F, Tang X, Liu W, Luo Z, Huang H, Liu M, Wang H, Liao S, Ma S, Jiang L, Zhang Y.   +10 more
europepmc   +1 more source

Patient Perspectives of Quality Compared to Quantity of Life Regarding Orbital Exenteration

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Orbital exenteration (OE) impacts patients cosmetically, functionally, and psychosocially. Eye‐sparing strategies with the advent of immunotherapy have developed the potential to avoid OE but may result in suboptimal oncologic outcomes and reduced survival.
Kalpesh Hathi, Colin MacKay, Robyn Macfarlane, S. Mark Taylor   +3 more
wiley   +1 more source